Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized S-ketamine inhalation pharmacokinetics and feasibility study in healthy adults
NL-OMON42367Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esketamine in pain and major depressive disorder (MDD), sponsored by Leiden University Medical Center. Primary endpoints: Safety and Pharmacokinetics. Started Aug 2015; status: active, not recruiting.
02
Drugs
esketamine
03
Conditions
painmajor depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON42367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42367.